Live·Verified funding discovery · 2026.2
874 grants · 19 open · 435 companies · 2640 concepts874 / 19 / 435 / 2640
COMPANIESCompanies rated · 435 (no change)PROJECTSProjects rated · 70 (no change)CATALOGUE874 grants in catalogue · 19 open right nowPOWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CACOMPANIESCompanies rated · 435 (no change)PROJECTSProjects rated · 70 (no change)CATALOGUE874 grants in catalogue · 19 open right nowPOWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA
← Back to Eternal Search

Padmanee Sharma

individual
Ecosystem influencer

About

Padmanee "Pam" Sharma, MD, PhD is an American cancer immunologist and oncologist at The University of Texas MD Anderson Cancer Center, where she serves as professor of Genitourinary Medical Oncology and Immunology, Associate VP of Immunobiology, and Director of Scientific Programs for the James P. Allison Institute. She is a prominent translational immunotherapy researcher known for pioneering neoadjuvant immune checkpoint therapy trials and for leadership in bladder, renal, and other solid-tumor immunotherapy. Public sources also show extensive scientific advisory and consulting roles across biotech companies and investment-adjacent organizations.

Areas of interest

cancer immunotherapyoncologytranslational medicinesolid tumorsbladder cancerrenal cancerprostate cancerimmune checkpoint therapyspatial biologyearly cancer detectionbiotech